//=time() ?>
Control of #CRISPR, biotech’s most promising breakthrough, is in dispute https://t.co/a4gU6IwGwK #Genomics
Biotech company develops way to carry antibodies across blood... http://t.co/WPfHUSy9Hf | https://t.co/esz87pilYR
The end of the boom of biotech stocks. Drawing for the @NewYorker